The New York Heart Association Classes and functional status: What are we really measuring?

Heart and Lung: Journal of Acute and Critical Care

Volumn 35, Issue 4, 2006, Pages 217-224

  Miller Davis, Claiborne ^a   Marden, Sue ^a   Leidy, Nancy Kline ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; DISEASE CLASSIFICATION; FUNCTIONAL STATUS; HEALTH CARE ORGANIZATION; HEART DISEASE; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; MEDICAL SOCIETY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

HEART DISEASES; HUMANS; NEW YORK; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; VENTRICULAR FUNCTION;

EID: 33746086010     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2006.01.003     Document Type: Article

References (38)

1. Coyne K.S., and Allen J.K. Assessment of functional status in patients with cardiac disease. Heart Lung 27 4 (1998) 263-273
2. Bennett J.A., Riegel B., Bittner V., and Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 31 4 (2002) 262-270
3. Leidy N.K. Functional status and the forward progress of merry-go-rounds. toward a coherent analytical framework. Nurs Res 43 4 (1994) 196-202
4. The Criteria Committee of the New York Heart Association. Functional Capacity and Objective Assessment. In: Dolgin M. (Ed). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. (1994), Little, Brown and Company, Boston, MA 253-255
5. McAlister F.A., Ezekowitz J.A., Wiebe N., Rowe B., Spooner C., Crumley E., et al. Systematic review. cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 141 5 (2004) 381-390
6. The Criteria Committee of the New York Heart Association. Cardiac Status and Prognosis. In: Harvey R. (Ed). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 7th ed. (1973), Little, Brown and Company, Boston, MA 286-287
7. Abdulla J., Kober L., and Torp-Pedersen C. Methods of assessing the functional status of patients with left ventricular systolic dysfunction in interventional studies. can brain natriuretic peptide measurement be used as surrogate for the traditional methods?. Cardiovasc Drugs Ther 18 3 (2004) 219-224
8. Kubo S.H., Schulman S., Starling R.C., Jessup M., Wentworth D., and Burkhoff D. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail 10 3 (2004) 228-235
9. Haas G.S., Hess H., Black M., Onnasch J., Mohr F.W., and van Son J.A. Extracardiac conduit Fontan procedure. early and intermediate results. Eur J Cardiothorac Surg 17 6 (2000) 648-654
10. Do Q.B., Pellerin M., Carrier M., Cartier R., Hebert Y., Page P., et al. Clinical outcome after isolated tricuspid valve replacement. 20-year experience. Can J Cardiol 16 4 (2000) 489-493
11. Ganiats T.G., Browner D.K., Dittrich H.C., and New York Heart Association. Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. Am Heart J 135 5 Pt 1 (1998) 819-824
12. Hauptman P.J., Masoudi F.A., Weintraub W.S., Pina I., Jones P.G., and Spertus J.A. Variability in the clinical status of patients with advanced heart failure. J Card Fail 10 5 (2004) 397-402
13. Maisel A., Hollander J.E., Guss D., McCullough P., Nowak R., Green G., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 6 (2004) 1328-1333
14. Torre-Amione G., Sestier F., Radovancevic B., and Young J. Effects of a novel immune modulation therapy in patients with advanced chronic heart failure. results of a randomized, controlled, phase II trial. J Am Coll Cardiol 44 6 (2004) 1181-1186
15. Deedwania P.C., Gottlieb S., Ghali J.K., Waagstein F., and Wikstrand J.C. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 25 15 (2004) 1300-1309
16. Anand I., McMurray J.J., Whitmore J., Warren M., Pham A., McCamish M.A., et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 110 2 (2004) 149-154
17. van den Berg-Emons R., Balk A., Bussmann H., and Stam H. Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?. Eur J Heart Fail 6 1 (2004) 95-100
18. Subramanian U., Fihn S.D., Weinberger M., Plue L., Smith F.E., Udris E.M., et al. A controlled trial of including symptom data in computer-based care. suggestions for managing patients with chronic heart failure. Am J Med 116 6 (2004) 375-384
19. Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Hanrath P., Komajda M., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET). randomised controlled trial. Lancet 362 9377 (2003) 7-13
20. Young J.B., Abraham W.T., Smith A.L., Leon A.R., Lieberman R., Wilkoff B., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. the MIRACLE ICD Trial. JAMA 289 20 (2003) 2685-2694
21. Freudenberger R.S., Schwarz Jr. R.P., Brown J., Moore A., Mann D., Givertz M.M., et al. Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III-IV congestive heart failure. Expert Opin Investig Drugs 13 11 (2004) 1509-1516
22. Muller K., Gamba G., Jaquet F., and Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV-efficacy and quality of life. Eur J Heart Fail 5 6 (2003) 793-801
23. Maliwa M.A., van der Heijden G.J., Bots M.L., van Hout B.A., Casselman F.P., van Swieten H., et al. Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg 11 5 (2003) 381-387
24. Hurst J.W. The approach to the patient. goals and cardiac appraisal. In: Hurst J.W. (Ed). The heart. 6th ed. (1986), McGraw-Hill, New York, NY 103-109
25. Westlake C., Dracup K., Fonarow G., and Hamilton M. Depression in patients with heart failure. J Card Fail 11 1 (2005) 30-35
26. Austin J., Williams R., Ross L., Moseley L., and Hutchison S. Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure. Eur J Heart Fail 7 3 (2005) 411-417
27. Nielson O., Sajedieh A., Petersen F., and Hansen J. Value of left ventricular filling parameters to predict mortality and functional class in patients with heart disease from the community. Eur J Echocardiography 6 (2005) 85-91
28. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 3 (2005) 225-237
29. MacVicar M. Functional assessment. concepts and measurement. In: Metzger B. (Ed). Altered functioning. impairment and disability (1991), Sigma Theta Tau, Indianapolis, IN 11
30. ASCM's guidelines for exercise testing and prescription (2000), Lippincott Williams and Wilkins, Philadelphia, PA
31. Leidy N.K., and Knebel A. Clinical validation of the functional performance inventory in patients with COPD. Respir Care 44 (1999) 932-939
32. Leidy N.K. Psychometric properties of the functional performance inventory in patients with chronic obstructive pulmonary disease. Nurs Res 48 1 (1999) 20-28
33. Ware J., and Kosinski M. SF-36 Physical and Mental Health Summary Scales. a manual for users of Version 1 (2001), Quality Metrics, Lincoln
34. Leidy N.K., Abbott R.D., and Fedenko K.M. Sensitivity and reproducibility of the dual-mode actigraph under controlled levels of activity intensity. Nurs Res 46 1 (1997) 5-11
35. Dinger M.K., Oman R.F., Taylor E.L., Vesely S.K., and Able J. Stability and convergent validity of the Physical Activity Scale for the Elderly (PASE). J Sports Med Phys Fitness 44 2 (2004) 186-192
36. Ware J., Snow K., and Kosinski M. The SF-36 Health Survey manual and interpretation guide (1997), The Health Institute New England Medical Center, Boston, MA
37. Spertus J.A., Winder J.A., Dewhurst T.A., Deyo R.A., Prodzinski J., McDonell M., et al. Development and evaluation of the Seattle Angina Questionnaire. a new functional status measure for coronary artery disease. J Am Coll Cardiol 25 2 (1995) 333-341
38. Grady K., Jalowiec A., Grusk B., White-Williams C., and Robinson J. Symptom distress in cardiac transplant candidates. Heart Lung 21 (1992) 434-439